Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | PLAU | P00749 | 1/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.39 |
| ▸ | TPSAB1 | Q15661 | 3/20 | 0.39 |
| ▸ | CYP51A1 | Q16850 | 2/20 | 0.38 |
| ▸ | SCN1A | P35498 | 1/20 | 0.37 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.37 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.36 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.36 |
| ▸ | NQO1 | P15559 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13449655 | 0.83 | ALDH1A1 (0.53) | CA1CA2CA5ACA9CA5B | |
| SCHEMBL23157115 | 0.83 | TP53 (0.42) | CA1CA2CA5ACA9CA5B | |
| SCHEMBL16674090 | 0.83 | ALDH1A1 (0.53) | CA1CA2CA5ACA9CA5B | |
| SCHEMBL28883487 | 0.81 | HDAC1 (0.46) | LMNASLC6A3 | |
| SCHEMBL29120529 | 0.80 | HDAC1 (0.45) | CA2CA9PLAULMNAMEN1 | |
| SCHEMBL30437401 | 0.80 | KMT2A (0.50) | CA2LMNAMEN1KMT2ANQO1 | |
| SCHEMBL21671191 | 0.78 | TP53 (0.38) | CA1CA2CA5ACA9CA5B | |
| SCHEMBL23623916 | 0.78 | HDAC8 (0.40) | CA1CA2CA5ACA9CA5B | |
| SCHEMBL14270104 | 0.77 | CA2 (0.52) | CA1CA2CA5ACA9CA5B | |
| SCHEMBL23157402 | 0.77 | IDO1 (0.48) | CA1CA2CA5ACA9CA5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118139851-A | Antitumor compounds | 法马马有限公司 | 2024-06-04 | — | — | CN | disclosed |
| EP-4138923-A1 | DRUG ANTIBODY CONJUGATES | Pharma Mar, S.A. (ES) | 2023-03-01 | — | — | EP | disclosed |
| EP-4114508-A1 | A SYSTEM AND METHOD FOR RELEASING A SPECIES | OBOE IPR AB (SE) | 2023-01-11 | — | — | EP | disclosed |
| EP-3630965-A1 | USE OF TERMINAL TRANSFERASE ENZYME IN NUCLEIC ACID SYNTHESIS | Nuclera Nucleics Ltd (GB) | 2020-04-08 | — | — | EP | disclosed |
| WO-2018215803-A1 | USE OF TERMINAL TRANSFERASE ENZYME IN NUCLEIC ACID SYNTHESIS | NUCLERA NUCLEICS LTD (GB) | 2018-11-29 | — | — | WO | disclosed |
| EP-2813512-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | Chugai Seiyaku Kabushiki Kaisha (JP) | 2014-12-17 | — | — | EP | disclosed |
| WO-2013100132-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | 中外製薬株式会社 (JP) | 2013-07-04 | — | — | WO | disclosed |